Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Valentin Tomazic

Showing results (51-60 of 69) with videos related to

Pageof 7
Sort By:
Clinical and Translational Allergy|January 31, 2026
Real-World Effectiveness of Mepolizumab in Patients With Chronic Rhinosinusitis With Nasal Polyps: Findings From the European CRS Outcome Registry (CHRINOSOR)Isam Alobid, Sven F Seys, Joost de Kinderen, et al.
Clinical and Translational Allergy|September 1, 2025
Characterization of Chronic Rhinosinusitis Patients Based on Markers of Type 2 Inflammation: Findings From the European CRS Outcome Registry (CHRINOSOR)Carlo Cavaliere, Sven F Seys, Joost de Kinderen, et al.
Allergy|December 18, 2023
EUFOREA/EPOS2020 statement on the clinical considerations for chronic rhinosinusitis with nasal polyps carePeter W Hellings, Isam Alobid, Wilma T Anselmo-Lima, et al.
The Journal of Allergy and Clinical Immunology. in Practice|October 22, 2022
Chronic Rhinosinusitis Outcome Registry (CHRINOSOR): Establishment of an International Outcome Registry Driven by mHealth TechnologySven F Seys, Peter W Hellings, Isam Alobid, et al.
The Journal of Allergy and Clinical Immunology. in Practice|August 25, 2019
Mobile Technology in Allergic Rhinitis: Evolution in Management or Revolution in Health and Care?Jean Bousquet, Ignacio J Ansotegui, Josep M Anto, et al.
Allergologie Select|June 23, 2020
Allergen immunotherapy in the current COVID-19 pandemic: A position paper of AeDA, ARIA, EAACI, DGAKI and GPA: Position paper of the German ARIA Group<sup>A</sup> in cooperation with the Austrian ARIA Group<sup>B</sup>, the Swiss ARIA Group<sup>C</sup>, German Society for Applied Allergology (AEDA)<sup>D</sup>, German Society for Allergology and Clinical Immunology (DGAKI)<sup>E</sup>, Society for Pediatric Allergology (GPA)<sup>F</sup> in cooperation with AG Clinical Immunology, Allergology and Environmental Medicine of the DGHNO-KHC<sup>G</sup> and the European Academy of Allergy and Clinical Immunology (EAACI)<sup>H</sup>Ludger Klimek, Oliver Pfaar, Margitta Worm, et al.
Allergy|May 20, 2020
Real-life assessment of chronic rhinosinusitis patients using mobile technology: The mySinusitisCoach project by EUFOREASven F Seys, Shana De Bont, Wytske J Fokkens, et al.
Clinical and Translational Allergy|September 27, 2021
Validity, reliability, and responsiveness of daily monitoring visual analog scales in MASK-air®Bernardo Sousa-Pinto, Patrik Eklund, Oliver Pfaar, et al.
Allergy|December 21, 2021
Development and validation of combined symptom-medication scores for allergic rhinitisBernardo Sousa-Pinto, Luís Filipe Azevedo, Marek Jutel, et al.
Allergy|March 8, 2022
Behavioural patterns in allergic rhinitis medication in Europe: A study using MASK-air<sup>®</sup> real-world dataBernardo Sousa-Pinto, Ana Sá-Sousa, Rafael José Vieira, et al.
Pageof 7

Showing results (51-60 of 69) with videos related to

Sort By:
Pageof 7
Clinical and Translational Allergy|January 31, 2026
Real-World Effectiveness of Mepolizumab in Patients With Chronic Rhinosinusitis With Nasal Polyps: Findings From the European CRS Outcome Registry (CHRINOSOR)Isam Alobid, Sven F Seys, Joost de Kinderen, et al.
Clinical and Translational Allergy|September 1, 2025
Characterization of Chronic Rhinosinusitis Patients Based on Markers of Type 2 Inflammation: Findings From the European CRS Outcome Registry (CHRINOSOR)Carlo Cavaliere, Sven F Seys, Joost de Kinderen, et al.
Allergy|December 18, 2023
EUFOREA/EPOS2020 statement on the clinical considerations for chronic rhinosinusitis with nasal polyps carePeter W Hellings, Isam Alobid, Wilma T Anselmo-Lima, et al.
The Journal of Allergy and Clinical Immunology. in Practice|October 22, 2022
Chronic Rhinosinusitis Outcome Registry (CHRINOSOR): Establishment of an International Outcome Registry Driven by mHealth TechnologySven F Seys, Peter W Hellings, Isam Alobid, et al.
The Journal of Allergy and Clinical Immunology. in Practice|August 25, 2019
Mobile Technology in Allergic Rhinitis: Evolution in Management or Revolution in Health and Care?Jean Bousquet, Ignacio J Ansotegui, Josep M Anto, et al.
Allergologie Select|June 23, 2020
Allergen immunotherapy in the current COVID-19 pandemic: A position paper of AeDA, ARIA, EAACI, DGAKI and GPA: Position paper of the German ARIA Group<sup>A</sup> in cooperation with the Austrian ARIA Group<sup>B</sup>, the Swiss ARIA Group<sup>C</sup>, German Society for Applied Allergology (AEDA)<sup>D</sup>, German Society for Allergology and Clinical Immunology (DGAKI)<sup>E</sup>, Society for Pediatric Allergology (GPA)<sup>F</sup> in cooperation with AG Clinical Immunology, Allergology and Environmental Medicine of the DGHNO-KHC<sup>G</sup> and the European Academy of Allergy and Clinical Immunology (EAACI)<sup>H</sup>Ludger Klimek, Oliver Pfaar, Margitta Worm, et al.
Allergy|May 20, 2020
Real-life assessment of chronic rhinosinusitis patients using mobile technology: The mySinusitisCoach project by EUFOREASven F Seys, Shana De Bont, Wytske J Fokkens, et al.
Clinical and Translational Allergy|September 27, 2021
Validity, reliability, and responsiveness of daily monitoring visual analog scales in MASK-air®Bernardo Sousa-Pinto, Patrik Eklund, Oliver Pfaar, et al.
Allergy|December 21, 2021
Development and validation of combined symptom-medication scores for allergic rhinitisBernardo Sousa-Pinto, Luís Filipe Azevedo, Marek Jutel, et al.
Allergy|March 8, 2022
Behavioural patterns in allergic rhinitis medication in Europe: A study using MASK-air<sup>®</sup> real-world dataBernardo Sousa-Pinto, Ana Sá-Sousa, Rafael José Vieira, et al.
Pageof 7